TAL Daiichi Life Lifts Challenger Takeover Offer

TAL Daiichi Life Australia has offered $12.20 per share for the Challenger shares it does not already own, after the board rejected a $11.80 bid last month.

Updated on Nov. 18, 2026 in Public Companies

TAL Daiichi Life Lifts Challenger Takeover Offer

Live Poll

Do you think big company takeovers usually benefit ordinary customers?

TAL Daiichi Life Australia has made an improved takeover offer for Challenger, seeking the remaining 79.5% of shares it does not already own at $12.20 per share. Challenger's board has rejected the revised offer, saying it does not adequately represent fair value for shareholders in a control transaction.

Why it matters

The proposal would give TAL full ownership of Challenger, a listed company, if shareholders accept the offer. The board's rejection of both the $11.80 and $12.20 offers means the price gap and the fair-value question remain the central issue for Australian investors.

The $12.20 per share offer sits about 2.1% above Challenger's last close of $11.95 and 3.4% above the rejected $11.80 bid. The unresolved question is whether the board would accept any price below its own view of fair value, which has not been quantified.

The players

TAL Daiichi Life Australia

TAL Daiichi Life Australia is the Australian life insurance business that already holds a 20.5% stake in Challenger and is seeking full ownership of the company.

Challenger

Challenger is a listed Australian retirement income and funds management company whose board has rejected both takeover proposals.

The details

TAL Daiichi Life Australia has proposed acquiring the 79.5% of Challenger shares it does not already hold, lifting its stake to 100%. Challenger's board rejected the earlier $11.80 bid last month and has now rejected the revised $12.20 offer as not adequately representing fair value.

Timeline

  1. Last month: Challenger's board rejected the $11.80 per share bid.

  2. 18 November 2026: TAL Daiichi Life Australia's improved $12.20 per share offer was reported.

Market Landscape

Bids for listed Australian financial services companies by insurance groups have often turned on whether boards judge the price to reflect fair value. Challenger's rejection of two successive offers places this approach in the same pattern of board resistance and incremental price increases.

Challenger shareholders must decide whether to accept the $12.20 offer or hold their shares, with the board's current recommendation against it. Shares trading near the offer price mean investors can sell on market rather than wait for a formal takeover outcome.

The takeaway

Takeover prices for listed companies often rise in steps as boards test whether a bidder will pay fair value. Shareholders comparing offers against the last trading price should weigh the board's reasoning alongside the premium on offer.

Further reading

Track more listed-company deal activity in the Public Companies section.

Live Poll

Do you think big company takeovers usually benefit ordinary customers?